MedBen Client Satisfaction Survey

Search

« Metro Hospital Preference Runs Counter to Study's Cost-Quality ConnectionMedBen Municipality Clients Experience Low 5-Year Cost Trend »

Insulin Costs, Diabetic Numbers on the Upswing

04/13/16

  09:35:00 pm, by MedBen5   , 212 words,  
Categories: News, Wellness, Research, Diabetes

Insulin Costs, Diabetic Numbers on the Upswing

diabetes

More evidence that a focused worksite wellness program like MedBen WellLiving can promote better health and save your business money: According to a new analysis, the cost of insulin to control diabetes more than tripled over a decade.

Stat reports that between 2002 and 2013, insulin prices spiked from $231 to $736 a year per patient. Currently, about one in four diabetes patients use insulin to manage their blood sugar, with the balance using pills or other injectable medicines.

The rising cost of insulin comes during a period of worldwide growth in diabetics. Data from the World Health Organization indicates that excess weight and obesity are among the factors that have led to nearly fourfold increase in diabetes cases over the last three decades.

MedBen WellLiving places an emphasis on helping your employees reduce their odds of developing Type 2 diabetes. Health plan members who are found to be at risk for the disease based on their claims history receive customized counseling from a RN Health Consultant via our Specialty Care Program.

Through one-on-one coaching, complemented by educational materials and other resources, plan members can reduce their chances of developing diabetes and the complications that accompany it. For more information about Specialty Care through MedBen WellLiving, contact Vice President of Sales & Marketing Brian Fargus at bfargus@medben.com.

No feedback yet